showed that MIF enhances the release of pro-inflammatory extracellular vesicles (EVs) through the CD74-ERK1/2-Myc signaling axis in colorectal cancer cells, thereby remodeling the immune microenvironment and sustaining inflammation-driven progression (39). Here, MAPK3 is linked to colorectal cancer.